| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.33M | 49.06M | 44.62M | 37.70M | 32.93M | 31.76M |
| Gross Profit | 24.34M | 24.20M | 19.64M | 14.70M | 12.02M | 10.29M |
| EBITDA | 5.02M | 3.54M | 88.12K | 169.30K | -1.47M | -235.14K |
| Net Income | 1.35M | 1.27M | -3.79M | 571.62K | -1.63M | -285.09K |
Balance Sheet | ||||||
| Total Assets | 45.51M | 46.12M | 41.86M | 21.83M | 17.03M | 16.92M |
| Cash, Cash Equivalents and Short-Term Investments | 11.96M | 12.23M | 6.10M | 13.55M | 10.60M | 11.00M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 29.92M | 32.19M | 30.17M | 14.50M | 12.14M | 11.49M |
| Stockholders Equity | 15.59M | 13.93M | 11.69M | 7.33M | 4.88M | 5.43M |
Cash Flow | ||||||
| Free Cash Flow | 7.25M | 7.00M | 3.48M | 3.34M | -461.49K | 1.85M |
| Operating Cash Flow | 7.29M | 7.02M | 3.55M | 3.38M | -417.20K | 1.87M |
| Investing Cash Flow | -36.80K | -19.26K | -10.10M | -344.66K | -44.29K | -19.85K |
| Financing Cash Flow | -2.22M | -877.88K | -905.85K | -97.26K | 63.27K | -159.97K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $94.98M | 76.66 | 9.49% | ― | 5.83% | ― | |
62 Neutral | $121.43M | 607.07 | 1.17% | ― | 14.20% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | $219.46M | -11.32 | -38.62% | ― | 159.00% | 33.19% | |
50 Neutral | $137.70M | -8.73 | -12.19% | ― | 4.71% | 11.12% | |
49 Neutral | $94.10M | -8.75 | -14.61% | ― | -1.83% | -642.89% | |
49 Neutral | $42.66M | 13.87 | ― | ― | ― | ― |
On December 10, 2025, William Nurthen resigned as Chief Financial Officer and Secretary of Research Solutions, Inc. to pursue another opportunity. Dave Kutil, who has been the company’s Global Controller since March 2023, was appointed as the Interim CFO and Secretary. Kutil brings over 15 years of financial leadership experience, having previously worked at Lesaffre Yeast Corporation and Badger Meter. His appointment is expected to maintain continuity in the company’s financial operations and strategic vision.
The most recent analyst rating on (RSSS) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Research Solutions stock, see the RSSS Stock Forecast page.
On November 12, 2025, Research Solutions held its annual meeting of stockholders, where 75.78% of the common stock was represented. During the meeting, six board members were elected, Wipfli LLP was ratified as the independent accountant for the fiscal year ending June 30, 2026, and executive compensation was approved. Additionally, it was decided that an advisory vote on executive compensation would be held every year.
The most recent analyst rating on (RSSS) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Research Solutions stock, see the RSSS Stock Forecast page.